Compare PAHC & LYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAHC | LYNX |
|---|---|---|
| Founded | 1946 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2014 | 2026 |
| Metric | PAHC | LYNX |
|---|---|---|
| Price | $37.88 | $13.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $44.00 | $19.67 |
| AVG Volume (30 Days) | 192.2K | ★ 448.3K |
| Earning Date | 11-04-2026 | 11-20-2026 |
| Dividend Yield | ★ 1.31% | N/A |
| EPS Growth | ★ 104.20 | N/A |
| EPS | ★ 2.43 | N/A |
| Revenue | ★ $833,350,000.00 | N/A |
| Revenue This Year | $3.83 | $35.28 |
| Revenue Next Year | $3.49 | $34.08 |
| P/E Ratio | $15.06 | ★ N/A |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $28.25 | $12.05 |
| 52 Week High | $60.08 | $14.10 |
| Indicator | PAHC | LYNX |
|---|---|---|
| Relative Strength Index (RSI) | 61.25 | 48.40 |
| Support Level | $36.47 | $12.13 |
| Resistance Level | $37.92 | $13.87 |
| Average True Range (ATR) | 1.27 | 0.67 |
| MACD | 0.27 | 0.02 |
| Stochastic Oscillator | 92.90 | 49.23 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Lyntris Inc is a defense technology company that develops connectivity solutions for military applications. Its products consist of interconnected subsystems designed to support defense and military customers in detecting threats, making decisions, and responding to operational requirements across multi-domain environments. The company serves U.S. and allied nation military customers. Its solutions are deployed across three core missions: Maritime Domain Awareness; Air & Missile Defense; and Space ISR & Resilient Communications. Maximum revenue is derived from the Maritime Domain Awareness business, which includes solutions focused on maritime monitoring, tracking and analysis that support government and defense customers in maintaining situational awareness across maritime environments.